terminal growth rate and discounted rate used in the assumptions are based on management of the subsidiary’s judgment and past experience and business plan, as well as the future prediction that is believed
quarter of 2017. The impairment of license was estimated the recoverable amount of value in use, determined by discounted future cash flows, the terminal growth rate and discounted rate used in the
future cash flows, the terminal growth rate and discounted rate used in the assumptions are based on management of the subsidiary and indirect subsidiary’s judgment and past experience and business plan
flows, the terminal growth rate and discounted rate used in the assumptions are based on management of the subsidiary and indirect subsidiary’s judgment and past experience and business plan, as well as
growth plans Indorama Ventures 1st Quarter 2018 MD&A 4 Portfolio Development We continue to upgrade our portfolio through organic growth, operational excellence initiatives, value accretive acquisitions
: +662 661 6664 1 3Q19 IVL Performance Summary IVL reported 3.3 mmt of production volume (5% organic and 18% inorganic growth yoy). Organic growth reinforces the demand growth in our business. Inorganic
6661 Fax: +662 661 6664 1 2019 IVL Performance Summary IVL registered volume growth of 18% in 2019 driven mainly by inorganic expansion. Industry-wide spreads declined to historical lows in 2019, leading
” reflecting the Company's successful strategy and future potential. 2017 Performance Analysis The Company achieved its highest-ever EBITDA of $ 1.004 billion in 2017, and achieved a 30% core EBITDA growth vis-à
” reflecting the Company's successful strategy and future potential. 2017 Performance Analysis The Company achieved its highest-ever EBITDA of $ 1.004 billion in 2017, and achieved a 30% core EBITDA growth vis-à
Reported EPS less Inventory gains/(losses) less one-time extraordinary items Indorama Ventures 3rd Quarter 2018 MD&A 3 Financial Highlights IVL continued its strong performance in 3Q 2018, with growth in